Catalog Number:
04491815190
SYSTEM INFORMATION
For cobas e 411 analyzer: test number 221
INTENDED USE
Immunoassay for the in vitro quantitative determination of troponin T in human serum and plasma. This assay can be used as
an aid in the differential diagnosis of acute coronary syndrome to identify necrosis, e.g. acute myocardial infarction. The
test is further indicated for the risk stratification of patients presenting with acute coronary syndrome and for cardiac
risk in patients with chronic renal failure. The test may also be useful for the selection of more intensive therapy and intervention
in patients with elevated levels of cardiac troponin T.
RESULTS ARE DETERMINED VIA A CALIBRATION CURVE WHICH IS INSTRUMENT-SPECIFICALLY GENERATED BY 2‑POINT CALIBRATION AND A MASTER
CURVE PROVIDED VIA THE REAGENT BARCODE OR E‑BARCODE.
STORAGE AND STABILITY
Store at 2‑8 °C.
CALIBRATION
Traceability: The Elecsys Troponin T assay (4th generation, 04491815) has been standardized against the Elecsys Troponin T STAT
assay (4th generation, 04660307). This in turn was originally standardized against the Enzymun‑Test Troponin T (CARDIAC T)
method.
EVERY ELECSYS REAGENT SET HAS A BARCODED LABEL CONTAINING SPECIFIC INFORMATION FOR CALIBRATION OF THE PARTICULAR REAGENT LOT.
THE PREDEFINED MASTER CURVE IS ADAPTED TO THE ANALYZER USING THE RELEVANT CALSET.
CALIBRATION MUST BE PERFORMED ONCE PER REAGENT LOT USING FRESH REAGENT (I.E. NOT MORE THAN 24 HOURS SINCE THE REAGENT KIT
WAS REGISTERED ON THE ANALYZER).
RENEWED CALIBRATION IS RECOMMENDED AS FOLLOWS:
CONTROLS FOR THE VARIOUS CONCENTRATION RANGES SHOULD BE RUN INDIVIDUALLY AT LEAST ONCE EVERY 24 HOURS WHEN THE TEST IS IN
USE, ONCE PER REAGENT KIT, AND FOLLOWING EACH CALIBRATION.
LIMITS AND RANGES
Measuring range
MEASURING RANGE
0.010‑25.0 µg/L or ng/mL (defined by the lower detection limit and the maximum of the master curve). Values below the lower
detection limit are reported as < 0.010 µg/L (ng/mL). Values above the measuring range are reported as > 25.0 µg/L or ng/mL
(or up to 250 µg/L or ng/mL for 10‑fold diluted samples).
0.010‑25.0 ΜG/L OR NG/ML (DEFINED BY THE LOWER DETECTION LIMIT AND THE MAXIMUM OF THE MASTER CURVE). VALUES BELOW THE LOWER
DETECTION LIMIT ARE REPORTED AS < 0.010 ΜG/L (NG/ML). VALUES ABOVE THE MEASURING RANGE ARE REPORTED AS > 25.0 ΜG/L OR NG/ML
(OR UP TO 250 ΜG/L OR NG/ML FOR 10‑FOLD DILUTED SAMPLES).
LOWER LIMITS OF MEASUREMENT
Lower detection limit of the test
SAMPLES WITH TROPONIN T CONCENTRATIONS ABOVE THE MEASURING RANGE CAN BE DILUTED WITH DILUENT UNIVERSAL. THE RECOMMENDED DILUTION
IS 1:10 (EITHER AUTOMATICALLY BY THE ANALYZERS OR MANUALLY). THE CONCENTRATION OF THE DILUTED SAMPLE MUST BE > 1.00 ΜG/L (NG/ML).
THE LOWEST CONCENTRATION WITH A CV LESS THAN OR EQUAL TO 10 % WITH THE ELECSYS TROPONIN T ASSAY WAS 0.030 ΜG/L (NG/ML) (INTERMEDIATE
WITHIN LOT PRECISION) OR 0.060 ΜG/L (NG/ML) (INTERMEDIATE LOT TO LOT PRECISION).
Precision was determined using Elecsys reagents, pooled human sera and controls in a modified protocol (EP5‑A) of the CLSI
(Clinical and Laboratory Standards Institute): 6 times daily for 10 days (n = 60); repeatability on MODULAR ANALYTICS E170
analyzer, n = 21. The following results were obtained:
SPECIFIC PERFORMANCE DATA
Representative performance data on the analyzers are given below.
PRECISION
Precision was determined using Elecsys reagents, pooled human sera and controls in a modified protocol (EP5‑A) of the CLSI
(Clinical and Laboratory Standards Institute): 6 times daily for 10 days (n = 60); repeatability on MODULAR ANALYTICS E170
analyzer, n = 21. The following results were obtained:
PRECISION WAS DETERMINED USING ELECSYS REAGENTS, POOLED HUMAN SERA AND CONTROLS IN A MODIFIED PROTOCOL (EP5‑A) OF THE CLSI
(CLINICAL AND LABORATORY STANDARDS INSTITUTE): 6 TIMES DAILY FOR 10 DAYS (N = 60); REPEATABILITY ON MODULAR ANALYTICS E170
ANALYZER, N = 21. THE FOLLOWING RESULTS WERE OBTAINED:
INTERMEDIATE PRECISION
INTERMEDIATE PRECISION
METHOD COMPARISON
A comparison of the Elecsys Troponin T assay (y) with the Elecsys Troponin T STAT assay (x) using clinical samples gave the
following correlations:
BABLOK W, PASSING H, BENDER R, ET AL. A GENERAL REGRESSION PROCEDURE FOR METHOD TRANSFORMATION. APPLICATION OF LINEAR REGRESSION
PROCEDURES FOR METHOD COMPARISON STUDIES IN CLINICAL CHEMISTRY,